ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

SQ

Shanghai Qilu Pharmaceutical Research and Development Center at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Shanghai Qilu Pharmaceutical Research and Development Center brings 3 presentations to ACR Convergence 2026 in Orlando. Its program centres on preclinical drug candidates for autoimmune disease, including a BCMA and CD19 dual-targeting T cell engager, a VAV1 molecular glue degrader and an anti-IFNAR1-TACI fusion protein tested in lupus models.

OrganizationACR Convergence 2026 Attendance
SQ
Shanghai Qilu Pharmaceutical Research and Development Center
Shanghai, China
Pharmaceutical companies
A pharmaceutical research and development organization.

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Shanghai Qilu Pharmaceutical Research and Development Center

Tell us what you sell and we’ll find the people at Shanghai Qilu Pharmaceutical Research and Development Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction